Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.

Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, Haidar A, Billah T, Huynh K, Ahmed U, Adery LL, Corcoran CM, Perkins DO, Schiffman J, Perez J, Mamah D, Ellman LM, Powers AR, Coleman MJ, Anticevic A, Fusar-Poli P, Kane JM, Kahn RS, McGorry PD, Bearden CE, Shenton ME, Nelson B, Calkins ME, Hendricks L, Bouix S, Addington J, McGlashan TH, Yung AR, Accelerating Medicines Partnership Schizophrenia, AMP SCZ Working Group and Subgroup leaders (not previously listed):, Allott K, Clark SR, Kapur T, Lavoie S, Lewandowski KE, Mathalon DH, Pasternak O, Stone WS, Torous J, National Institute of Mental Health Project Scientists:, Rowland LM, Zhan M, Research Network and DPACC Investigators (not previously listed):, Amminger P, Arango C, Broome MR, Cadenhead KS, Chen EYH, Choi J, Kevin Cho KI, Conus P, Cornblatt BA, Glenthøj LB, Horton LE, Kambeitz J, Keshavan MS, Koutsouleris N, Langbein K, Diaz-Caneja CM, Mittal VA, Nordentoft M, Gaspar Ramos PA, Pearlson GD, Shah JL, Smesny S, Strauss GP, Wang J, Study Coordinators and Project Managers (not previously listed):, Marcy PJ, Matneja P, Phassouliotis C, Ray S, Snowball C, Spark J, Tod S, Individual names of AMP SCZ collaborators are listed in the Acknowledgment. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS. medRxiv. 2023 May 02.

2023
https://researcherprofiles.org/profile/396766412
37205422

Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, Haidar A, Billah T, Huynh K, Ahmed U, Adery LL, Corcoran CM, Perkins DO, Schiffman J, Perez J, Mamah D, Ellman LM, Powers AR, Coleman MJ, Anticevic A, Fusar-Poli P, Kane JM, Kahn RS, McGorry PD, Bearden CE, Shenton ME, Nelson B, Calkins ME, Hendricks L, Bouix S, Addington J, McGlashan TH, Yung AR, Accelerating Medicines Partnership Schizophrenia, AMP SCZ Working Group and Subgroup leaders (not previously listed):, Allott K, Clark SR, Kapur T, Lavoie S, Lewandowski KE, Mathalon DH, Pasternak O, Stone WS, Torous J, National Institute of Mental Health Project Scientists:, Rowland LM, Zhan M, Research Network and DPACC Investigators (not previously listed):, Amminger P, Arango C, Broome MR, Cadenhead KS, Chen EYH, Choi J, Kevin Cho KI, Conus P, Cornblatt BA, Glenthøj LB, Horton LE, Kambeitz J, Keshavan MS, Koutsouleris N, Langbein K, Diaz-Caneja CM, Mittal VA, Nordentoft M, Gaspar Ramos PA, Pearlson GD, Shah JL, Smesny S, Strauss GP, Wang J, Study Coordinators and Project Managers (not previously listed):, Marcy PJ, Matneja P, Phassouliotis C, Ray S, Snowball C, Spark J, Tod S, Individual names of AMP SCZ collaborators are listed in the Acknowledgment